Rallybio Corporation RLYB Q4 2025 Annual earnings
Reported March 12, 2026 · Before market open
Revenue$222.0KBeat by $122.0K
EPS-$1.28Miss by $0.04
Revenue estimate$100.0K
EPS estimate-$1.24
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$216.5K
EPS estimate-$1.28
Versus estimates
Revenue
Diluted EPS
Ask the moment Rallybio Corporation reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Rallybio Corporation report Q4 2025 earnings?
- Rallybio Corporation (RLYB) reported Q4 2025 earnings on March 12, 2026 before market open.
- What were Rallybio Corporation's Q4 2025 revenue and EPS?
- Rallybio Corporation reported revenue of $222.0K and eps of $-1.28 for Q4 2025.
- Did Rallybio Corporation beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $100.0K by $122.0K. EPS missed the consensus estimate of $-1.24 by $0.04.
- How did Rallybio Corporation's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 484.2% from $38.0K a year earlier and eps declined 412.0% from $-0.25.
- Where can I find Rallybio Corporation's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001628280-26-018261) directly on SEC EDGAR. The filing index links above go to sec.gov.